Agenda of the COMP meeting 7-8 October 2025

Human medicines European public assessment report (EPAR): Rixathon, rituximab, Date of authorisation: 15/06/2017, Revision: 15, Status: Authorised

Scientific advice on MRL classification of chemical-unlike biological substances considered as not requiring an MRL evaluation according to Regulation (EU) 2018/782

Business hours and holidays

Human medicines European public assessment report (EPAR): Capvaxive, pneumococcal polysaccharide conjugate vaccine (21-valent), Date of authorisation: 24/03/2025, Revision: 3, Status: Authorised

PRAC: Working parties and other groups of interest

PRAC Interest Group on Measuring the Impact of Pharmacovigilance Activities (PRAC IG Impact)

Granularity and Periodicity Advisory Group

Timetable: Companion diagnostic follow-up consultation

Timetable: Companion diagnostic follow-up consultation - ATMP